Michigan State University
East Lansing, Michigan, 48824, United States
Location status: Recruiting
NCT Number: NCT07485608
The objective of this study is to assess the effectiveness of portable air filtration (PAF) for mitigating lead dust exposures and reducing childhood blood lead levels in older housing.
Interested in participating?
Request InfoUp to 7 year
All sexes
Interventional
Not applicable
East Lansing, Michigan, 48824, United States
Location status: Recruiting
In close collaboration with local health departments, this project will enroll 40 participants who (1) reside in housing built before 1970, and (2) have children under six years of age with blood lead levels (BLL) >5 μg/dL. Specific objectives include (1) assess reduction of Pb dust exposure via the intervention, (2) assess the ability of PAF to reduce childhood BLL indirectly via reductions in Pb dust exposure, and (3) develop evidence-based exposure reduction guidance for wider public use of PAF. The project team will measure Pb levels in (1) suspended dust, (2) floor dust, and (3) children's blood before the start and finish of the two-month-long intervention as well as at the midpoint.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two portable air filtration units placed in subjects' homes (one in child's bedroom and one in living room) will be kept running for two months.
Time frame: After two months at the end of the intervention
change in blood lead level (in ug/dL).
Contact information is provided by the study sponsor or research team.
Masako Morishita, PhD
CONTACT
Tuan Nguyen, BS
CONTACT
Michigan State University
Other
Reducing Lead Dust Exposure and Childhood Blood Lead Levels in Older Housing in Michigan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02068183
Asthma, Bronchial Diseases
New York, United States
View Trial DetailsNCT05507021
Elevated Blood Lead Levels
Mexico City, Mexico
View Trial DetailsNCT04891666
Elevated Blood Lead Levels
Beijing, Beijing Municipality, China
View Trial DetailsNCT02745873
Elevated Blood Lead Levels
View Trial Details